M1 KLINIKEN AG (M12.DE) Stock Fundamental Analysis
FRA:M12 - Deutsche Boerse Ag - DE000A0STSQ8 - Common Stock - Currency: EUR
Taking everything into account, M12 scores 7 out of 10 in our fundamental rating. M12 was compared to 26 industry peers in the Health Care Providers & Services industry. M12 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. M12 is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make M12 a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year M12 was profitable.
M12 had a positive operating cash flow in the past year.
M12 had positive earnings in each of the past 5 years.
Each year in the past 5 years M12 had a positive operating cash flow.
1.2 Ratios
M12's Return On Assets of 8.53% is amongst the best of the industry. M12 outperforms 96.15% of its industry peers.
The Return On Equity of M12 (15.10%) is better than 80.77% of its industry peers.
M12 has a Return On Invested Capital of 12.86%. This is amongst the best in the industry. M12 outperforms 96.15% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for M12 is in line with the industry average of 5.89%.
The 3 year average ROIC (7.72%) for M12 is below the current ROIC(12.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.53% | ||
| ROE | 15.1% | ||
| ROIC | 12.86% |
ROA(3y)5.18%
ROA(5y)4.73%
ROE(3y)9.59%
ROE(5y)9.22%
ROIC(3y)7.72%
ROIC(5y)6.16%
1.3 Margins
With a decent Profit Margin value of 4.72%, M12 is doing good in the industry, outperforming 76.92% of the companies in the same industry.
M12's Profit Margin has declined in the last couple of years.
M12 has a Operating Margin of 7.89%. This is in the better half of the industry: M12 outperforms 65.38% of its industry peers.
In the last couple of years the Operating Margin of M12 has declined.
With a Gross Margin value of 18.75%, M12 is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
M12's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.89% | ||
| PM (TTM) | 4.72% | ||
| GM | 18.75% |
OM growth 3Y27.08%
OM growth 5Y-5.31%
PM growth 3Y18.61%
PM growth 5Y-17.82%
GM growth 3Y2.18%
GM growth 5Y-14.45%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so M12 is creating value.
The number of shares outstanding for M12 has been reduced compared to 1 year ago.
The number of shares outstanding for M12 has been increased compared to 5 years ago.
M12 has a worse debt/assets ratio than last year.
2.2 Solvency
M12 has an Altman-Z score of 5.26. This indicates that M12 is financially healthy and has little risk of bankruptcy at the moment.
M12 has a better Altman-Z score (5.26) than 96.15% of its industry peers.
M12 has a debt to FCF ratio of 0.71. This is a very positive value and a sign of high solvency as it would only need 0.71 years to pay back of all of its debts.
M12 has a better Debt to FCF ratio (0.71) than 100.00% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that M12 is not too dependend on debt financing.
M12 has a Debt to Equity ratio of 0.07. This is amongst the best in the industry. M12 outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.71 | ||
| Altman-Z | 5.26 |
ROIC/WACC1.82
WACC7.05%
2.3 Liquidity
A Current Ratio of 1.91 indicates that M12 should not have too much problems paying its short term obligations.
M12 has a better Current ratio (1.91) than 84.62% of its industry peers.
M12 has a Quick Ratio of 1.07. This is a normal value and indicates that M12 is financially healthy and should not expect problems in meeting its short term obligations.
M12's Quick ratio of 1.07 is fine compared to the rest of the industry. M12 outperforms 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 55.90% over the past year.
Measured over the past 5 years, M12 shows a small growth in Earnings Per Share. The EPS has been growing by 7.97% on average per year.
M12 shows a small growth in Revenue. In the last year, the Revenue has grown by 7.23%.
M12 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.44% yearly.
EPS 1Y (TTM)55.9%
EPS 3Y21.62%
EPS 5Y7.97%
EPS Q2Q%-10.77%
Revenue 1Y (TTM)7.23%
Revenue growth 3Y2.54%
Revenue growth 5Y34.44%
Sales Q2Q%3.58%
3.2 Future
The Earnings Per Share is expected to grow by 19.66% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.24% on average over the next years. This is quite good.
EPS Next Y15.41%
EPS Next 2Y19.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.37%
Revenue Next 2Y7.19%
Revenue Next 3Y7.36%
Revenue Next 5Y8.24%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
M12 is valuated rather expensively with a Price/Earnings ratio of 17.56.
Based on the Price/Earnings ratio, M12 is valued a bit cheaper than the industry average as 65.38% of the companies are valued more expensively.
M12's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.35.
With a Price/Forward Earnings ratio of 14.84, M12 is valued correctly.
Based on the Price/Forward Earnings ratio, M12 is valued a bit cheaper than 61.54% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of M12 to the average of the S&P500 Index (22.19), we can say M12 is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.56 | ||
| Fwd PE | 14.84 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, M12 is valued a bit cheaper than the industry average as 65.38% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, M12 is valued a bit cheaper than 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.57 | ||
| EV/EBITDA | 8.66 |
4.3 Compensation for Growth
M12's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
M12 has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as M12's earnings are expected to grow with 19.66% in the coming years.
PEG (NY)1.14
PEG (5Y)2.2
EPS Next 2Y19.66%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.35%, M12 has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.74, M12 pays a better dividend. On top of this M12 pays more dividend than 92.31% of the companies listed in the same industry.
M12's Dividend Yield is a higher than the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y19.66%
EPS Next 3YN/A
FRA:M12 (6/19/2025, 7:00:00 PM)
14.4
-0.22 (-1.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners0.96%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap282.82M
Analysts85
Price Target27.03 (87.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.35% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.92%
PT rev (3m)-3.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.67%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.56 | ||
| Fwd PE | 14.84 | ||
| P/S | 0.83 | ||
| P/FCF | 9.57 | ||
| P/OCF | 9.26 | ||
| P/B | 2.67 | ||
| P/tB | 15.18 | ||
| EV/EBITDA | 8.66 |
EPS(TTM)0.82
EY5.69%
EPS(NY)0.97
Fwd EY6.74%
FCF(TTM)1.5
FCFY10.45%
OCF(TTM)1.56
OCFY10.8%
SpS17.27
BVpS5.4
TBVpS0.95
PEG (NY)1.14
PEG (5Y)2.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.53% | ||
| ROE | 15.1% | ||
| ROCE | 18.56% | ||
| ROIC | 12.86% | ||
| ROICexc | 15.5% | ||
| ROICexgc | 57.73% | ||
| OM | 7.89% | ||
| PM (TTM) | 4.72% | ||
| GM | 18.75% | ||
| FCFM | 8.71% |
ROA(3y)5.18%
ROA(5y)4.73%
ROE(3y)9.59%
ROE(5y)9.22%
ROIC(3y)7.72%
ROIC(5y)6.16%
ROICexc(3y)9.69%
ROICexc(5y)8.26%
ROICexgc(3y)31.7%
ROICexgc(5y)24.88%
ROCE(3y)11.15%
ROCE(5y)8.88%
ROICexcg growth 3Y38.16%
ROICexcg growth 5Y31.27%
ROICexc growth 3Y22.22%
ROICexc growth 5Y5.12%
OM growth 3Y27.08%
OM growth 5Y-5.31%
PM growth 3Y18.61%
PM growth 5Y-17.82%
GM growth 3Y2.18%
GM growth 5Y-14.45%
F-Score9
Asset Turnover1.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 0.71 | ||
| Debt/EBITDA | 0.23 | ||
| Cap/Depr | 19.3% | ||
| Cap/Sales | 0.29% | ||
| Interest Coverage | 17.5 | ||
| Cash Conversion | 95.72% | ||
| Profit Quality | 184.48% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.07 | ||
| Altman-Z | 5.26 |
F-Score9
WACC7.05%
ROIC/WACC1.82
Cap/Depr(3y)22.84%
Cap/Depr(5y)24.89%
Cap/Sales(3y)0.41%
Cap/Sales(5y)0.51%
Profit Quality(3y)272.44%
Profit Quality(5y)207.18%
High Growth Momentum
Growth
EPS 1Y (TTM)55.9%
EPS 3Y21.62%
EPS 5Y7.97%
EPS Q2Q%-10.77%
EPS Next Y15.41%
EPS Next 2Y19.66%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.23%
Revenue growth 3Y2.54%
Revenue growth 5Y34.44%
Sales Q2Q%3.58%
Revenue Next Year6.37%
Revenue Next 2Y7.19%
Revenue Next 3Y7.36%
Revenue Next 5Y8.24%
EBIT growth 1Y69.16%
EBIT growth 3Y30.31%
EBIT growth 5Y27.31%
EBIT Next Year28.34%
EBIT Next 3Y33.77%
EBIT Next 5YN/A
FCF growth 1Y49.16%
FCF growth 3Y27.23%
FCF growth 5YN/A
OCF growth 1Y46.7%
OCF growth 3Y24.88%
OCF growth 5YN/A